About SD Biosensor
SD Biosensor is a company based in Suwon (South Korea) founded in 2001. The company has 613 employees as of December 31, 2024. SD Biosensor has completed 4 acquisitions, including Bestbion, ECO Diagnostica and Meridian Bioscience. SD Biosensor offers products and services including STANDARD Q, STANDARD F, STANDARD E, STANDARD M, and BGMS. SD Biosensor operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Suwon, South Korea
- Employees 613 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sd Biosensor, Inc.
-
Annual Revenue
$470.92 M (USD)5.93as on Dec 31, 2024
-
Net Profit
-$66.72 M (USD)78.96as on Dec 31, 2024
-
EBITDA
$59.14 M (USD)0as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
613
as on Dec 31, 2024
-
Investments & Acquisitions
Bestbion
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SD Biosensor
SD Biosensor is a publicly listed company on the KRX with ticker symbol 137310 in South Korea, operating in the Electronic technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SD Biosensor
SD Biosensor offers a comprehensive portfolio of products and services, including STANDARD Q, STANDARD F, STANDARD E, STANDARD M, and BGMS.
Offers rapid diagnostic tests for various infectious diseases.
Provides multi-parametric analysis for accurate laboratory results.
Delivers reliable enzyme assays for mass screening purposes.
Enables point-of-care testing for faster clinical decisions.
Monitors blood glucose levels with high accuracy and quality.
People of SD Biosensor
Unlock access to complete
Funding Insights of SD Biosensor
Investors in SD Biosensor
SD Biosensor has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked |
Investor details for SD Biosensor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SD Biosensor
SD Biosensor has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Bestbion, ECO Diagnostica and Meridian Bioscience.
Investment portfolio details for SD Biosensor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Portfolio of diagnostic products
|
Locked | Locked | 2012 | Locked | |
|
Clinical testing products and diagnostic tests are developed for laboratories.
|
Locked | Locked | 2011 | Locked | |
|
Reagents and instrumentation for in vitro diagnostics are developed.
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for SD Biosensor
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SD Biosensor
Detailed financials for SD Biosensor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sd Biosensor Comparisons
Peer comparison for SD Biosensor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SD Biosensor
SD Biosensor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of SD Biosensor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sd Biosensor
Complete news archive for SD Biosensor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SD Biosensor
SD Biosensor was founded in 2001 and raised its 1st funding round 19 years after it was founded.
SD Biosensor is headquartered in Suwon, South Korea. It is registered at Suwon, Gyeonggi, South Korea.
As of Dec 31, 2024, the latest employee count at SD Biosensor is 613.
Annual revenue of SD Biosensor is $470.92M as on Dec 31, 2024.
SD Biosensor was founded in 2001 and is based in Suwon-si, South Korea. The company operates in the medical diagnostics sector, where biosensors for point-of-care applications are developed. Three primary products form the SD product line: SD A1care functions as an immunochromatographic analyzer for measuring HbA1c levels in blood samples, SD Lipidocare is designed for monitoring cholesterol levels in blood, and SD GlucoNavii enables rapid glucose measurements.
SD Biosensor's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
SD Biosensor offers STANDARD Q, STANDARD F, STANDARD E, STANDARD M, and BGMS.
Yes, SD Biosensor is publicly traded on KRX under the ticker symbol 137310.
SD Biosensor has made 4 acquisitions, including Bestbion, ECO Diagnostica, and Meridian Bioscience.
SD Biosensor has 1 investor. Key investors include Gates Foundation.
The ticker symbol of SD Biosensor is 137310 on KRX.